Analyte | Day 1 RE 500 mg BID(N = 16) | Day 13 RE 500 mg BID(N = 15) | ||||
AUC(0-tau) or AUC (0-last)a (hr.ng/ml) | Cmax (ng/ml) | tmax (hr) | AUC(0-tau) or AUC (0-last)a (hr.ng/ml) | Cmax (ng/ml) | tmax (hr) | |
RE | 70.9 (45) | 64.8 (55) | 0.63 (0.25–3.0) | 73.5 (47) | 53.3 (94) | 0.50 (0.25–4.0) |
Remogliflozin | 4894 (40) | 1999 (60) | 0.77 (0.50–6.0) | 4928 (33) | 1494 (39) | 3.0 (0.5–4.0) |
GSK279782 (active metabolite) | 878 (44) | 257 (51) | 1.3 (0.75–6.0) | 1053 (44) | 251 (49) | 4.0 (0.5–4.0) |
Analyte | Day 1 RE 750 mg BID (N = 17) | Day 13 RE 750 mg BID (N= 16) | ||||
RE | 121 (39) | 137 (74) | 0.50 (0.25–2.5) | 121 (41) | 101 (74) | 0.48 (0.22–2.6) |
Remogliflozin | 8515 (31) | 4008 (46) | 0.75 (0.50–2.5) | 6996 (39) | 2508 (65) | 1.3 (0.50–4.0) |
GSK279782 (active metabolite) | 1600 (50) | 528 (43) | 1.0 (0.75–3.0) | 1298 (42) | 326 (49) | 3.0 (0.6–4.1) |